Psychotherapeutic intervention in somatisation disorder: results of a controlled study from India.
Somatisation disorder is a chronic condition often associated with poor response to treatment, troublesome symptoms, distress, disability and burden. Psychosocial interventions have an important role to play in treatment. However, there is a lack of controlled studies especially from the non-western world. The present study assessed the efficacy of non-pharmacological interventions in somatisation disorder using a case control design. Fifteen patients each diagnosed as somatisation disorder as per ICD DCR criteria received six sessions of a specific psychological intervention (designed specifically for the study) or a non-specific psychological intervention along with fluoxetine. The subjects were followed up for 8 weeks. Assessments were carried out at 0, 4 and 8 weeks using structured measures. Mean age of the sample was 33 ± 7.11 years. Both the groups suffered moderate level of depression, anxiety and disability, and high neuroticism and subjective distress as measured on different instruments. A significant improvement was observed in both the groups in all the measures following the intervention. The group receiving the specific interventions showed more improvement. The study concludes that both specific as well as non specific psychotherapeutic interventions can bring substantial improvement in patients with somatisation disorder, with more improvement seen with specific psychotherapeutic interventions.
All India Institute of Medical Sciences , New Delhi, India.
Vijeta
V
Kushwaha
Rakesh K
RK
Chadda
Manju
M
Mehta
D000328:Adult; D001945:Breathing Exercises; D003131:Combined Modality Therapy; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D007194:India; D008297:Male; D011340:Problem Solving; D011613:Psychotherapy / Q000379:methods*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013001:Somatoform Disorders / Q000628:therapy*; D016896:Treatment Outcome
D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors